| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Przemysław Paweł Taciak, Natalia Lysenko, Aleksander Paweł Mazure. Drugs which influence serotonin transporter and serotonergic receptors: Pharmacological and clinical properties in the treatment of depression. Pharmacological reports : PR. vol 70. issue 1. 2018-09-07. PMID:29309998. |
drugs which influence serotonin transporter and serotonergic receptors: pharmacological and clinical properties in the treatment of depression. |
2018-09-07 |
2023-08-13 |
Not clear |
| Faruk Ugu. Better Tolerance of Citalopram in a Breastfed Infant Who Could Not Tolerate Sertraline and Paroxetine. Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine. vol 13. issue 1. 2018-09-06. PMID:29185803. |
first-line antidepressants in treatment of postpartum depression are selective serotonin reuptake inhibitors (ssris). |
2018-09-06 |
2023-08-13 |
Not clear |
| Luiz Fernando Veríssimo, Vinicius Lucca Volpini, Viviane Batista Estrada, Natália Kimie Matsubara, Marcus Vinicius Gomes, Leonardo Barbosa Moraes Resstel, Fernando Morgan Aguiar Correa, Gislaine Garcia Pelos. Treatment with escitalopram modulates cardiovascular function in rats. European journal of pharmacology. vol 824. 2018-09-06. PMID:29428469. |
considering depression is three times more common in cardiac patients compared to the normal population and selective serotonin reuptake inhibitors (ssri) as drug of choice for treating patients with cardiovascular disease and depression, our work aims to evaluate the cardiovascular effects of treatment for 21 days with escitalopram (5 mg/kg/day, ip) in rats. |
2018-09-06 |
2023-08-13 |
rat |
| Hitomi Suga, Keiko Asakura, Satomi Kobayashi, Masanori Nojima, Satoshi Sasak. Association between habitual tryptophan intake and depressive symptoms in young and middle-aged women. Journal of affective disorders. vol 231. 2018-08-29. PMID:29438897. |
the intake of tryptophan, the precursor of serotonin, is assumed to affect serotonin availability and depression onset. |
2018-08-29 |
2023-08-13 |
Not clear |
| Kun Li, Si Shen, Yu-Tian Ji, Xu-Yun Li, Li-San Zhang, Xiao-Dong Wan. Melatonin Augments the Effects of Fluoxetine on Depression-Like Behavior and Hippocampal BDNF-TrkB Signaling. Neuroscience bulletin. vol 34. issue 2. 2018-08-28. PMID:29086908. |
depression is a debilitating psychiatric disorder with a huge socioeconomic burden, and its treatment relies on antidepressants including selective serotonin reuptake inhibitors (ssris). |
2018-08-28 |
2023-08-13 |
mouse |
| Xiaotao Li, Xiang L. The Antidepressant Effect of Light Therapy from Retinal Projections. Neuroscience bulletin. vol 34. issue 2. 2018-08-28. PMID:29430586. |
we finally emphasize the function of the retino-raphe projection in modulating serotonin activity, which probably underlies the antidepressant effect of light therapy for depression. |
2018-08-28 |
2023-08-13 |
Not clear |
| Lucie Cazet, Samuel Bulteau, Adrien Evin, Andrew Spiers, Pascal Caillet, Emmanuelle Kuhn, Jacques Pivette, Anicet Chaslerie, Pascale Jolliet, Caroline Victorri-Vignea. Interaction between CYP2D6 inhibitor antidepressants and codeine: is this relevant? Expert opinion on drug metabolism & toxicology. vol 14. issue 8. 2018-08-24. PMID:29963937. |
selective serotonin reuptake inhibitors (ssris) or serotonin and norepinephrine reuptake inhibitors (snris) are first-line pharmacotherapies for depression and inhibit many cytochrome 2d6 enzymes. |
2018-08-24 |
2023-08-13 |
Not clear |
| Paul Cumming, Gregor Gryglewski, Georg S Kranz, Rupert Lanzenberge. Commentary: The serotonin transporter in depression: Meta-analysis of in vivo and post mortem findings and implications for understanding and treating depression. Journal of affective disorders. vol 199. 2018-08-22. PMID:27057649. |
commentary: the serotonin transporter in depression: meta-analysis of in vivo and post mortem findings and implications for understanding and treating depression. |
2018-08-22 |
2023-08-13 |
Not clear |
| Joseph Kambeitz, Oliver D Howe. Consistent biological findings in major depression: Results from serotonin transporter meta-analyses. Journal of affective disorders. vol 199. 2018-08-22. PMID:27128823. |
consistent biological findings in major depression: results from serotonin transporter meta-analyses. |
2018-08-22 |
2023-08-13 |
Not clear |
| Lee S Cohen, Ruta Nonac. Neurodevelopmental Implications of Fetal Exposure to Selective Serotonin Reuptake Inhibitors and Untreated Maternal Depression: Weighing Relative Risks. JAMA psychiatry. vol 73. issue 11. 2018-08-06. PMID:27732715. |
neurodevelopmental implications of fetal exposure to selective serotonin reuptake inhibitors and untreated maternal depression: weighing relative risks. |
2018-08-06 |
2023-08-13 |
Not clear |
| Janet Best, H F Nijhout, Srimal Samaranayake, Parastoo Hashemi, Michael Ree. A mathematical model for histamine synthesis, release, and control in varicosities. Theoretical biology & medical modelling. vol 14. issue 1. 2018-07-24. PMID:29228949. |
it is known that high ha levels in the extracellular space inhibit serotonin release, so ha may play a role in the etiology of depression. |
2018-07-24 |
2023-08-13 |
Not clear |
| Jessica L Bolton, Melanie G Wiley, Bailey Ryan, Samantha Truong, Melva Strait, Dana Creighton Baker, Nancy Y Yang, Olga Ilkayeva, Thomas M O'Connell, Shelley W Wroth, Cristina L Sánchez, Geeta Swamy, Christopher Newgard, Cynthia Kuhn, Staci D Bilbo, Leigh Ann Simmon. Perinatal western-type diet and associated gestational weight gain alter postpartum maternal mood. Brain and behavior. vol 7. issue 10. 2018-07-09. PMID:29075574. |
we investigated whether perinatal consumption of a western-type diet (high in fat and branched-chain amino acids [bcaa]) and associated gestational weight gain (gwg) cause serotonin dysregulation in the central nervous system (cns), resulting in postpartum depression and anxiety (ppd/a). |
2018-07-09 |
2023-08-13 |
Not clear |
| Margarita Prokofieva, Georgia Karadima, Evmorfia Koukia, Vassiliki Michou, Chrysoula Kyprianidou, Chrysovalantis V Papageorgiou, Evangelos Alexiadis, Pantelis Constantoulakis, Dimitris Dikeo. Association of 5-HTTLPR Polymorphism with the Nursing Diagnoses and the Achievement of Nursing Outcomes in Patients with Major Depression. Issues in mental health nursing. vol 38. issue 10. 2018-07-06. PMID:29016262. |
the aim of this study is to investigate whether a 44-base-pair insertion/deletion polymorphism in the upstream regulatory region of the serotonin transporter gene (5-httlpr) is associated with the nursing diagnoses and the achievement of the desired nursing outcomes in inpatients with major depression. |
2018-07-06 |
2023-08-13 |
Not clear |
| Bonnie Klimes-Dougan, Melinda Westlund Schreiner, Michelle Thai, Meredith Gunlicks-Stoessel, Kristina Reigstad, Kathryn R Culle. Neural and neuroendocrine predictors of pharmacological treatment response in adolescents with depression: A preliminary study. Progress in neuro-psychopharmacology & biological psychiatry. vol 81. 2018-07-03. PMID:29100972. |
typically, about 30 to 50% of adolescents with depression fail to respond to evidence-based treatments, including antidepressant medications such as selective serotonin reuptake inhibitors (ssris). |
2018-07-03 |
2023-08-13 |
Not clear |
| Foteini Delis, André F Carvalho, Nafsika Poulia, Petros Bozidis, Vassiliki Paika, Elisavet Ntountoulaki, Dimitra Papaioannou, Else Guthrie, Katerina Antoniou, Thomas N Hyphanti. Resilience Mediates the Influence of a Polymorphism in the Serotonin Transporter Gene on the Relationship between the Burden of Chronic Illness and Depression. Psychotherapy and psychosomatics. vol 86. issue 5. 2018-06-25. PMID:28903099. |
resilience mediates the influence of a polymorphism in the serotonin transporter gene on the relationship between the burden of chronic illness and depression. |
2018-06-25 |
2023-08-13 |
Not clear |
| Vanda Faria, Malin Gingnell, Johanna M Hoppe, Olof Hjorth, Iman Alaie, Andreas Frick, Sara Hultberg, Kurt Wahlstedt, Jonas Engman, Kristoffer N T Månsson, Per Carlbring, Gerhard Andersson, Margareta Reis, Elna-Marie Larsson, Mats Fredrikson, Tomas Furmar. Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial. EBioMedicine. vol 24. 2018-06-18. PMID:29033138. |
selective serotonin reuptake inhibitors (ssris) are commonly prescribed for depression and anxiety, but their efficacy relative to placebo has been questioned. |
2018-06-18 |
2023-08-13 |
Not clear |
| Sayo Matsuoka, Satoko Hori, Hiroki Satoh, Takeshi Nagamatsu, Tomoyuki Fujii, Yasufumi Sawad. Quantitative prediction of fetal plasma concentration of fluvoxamine during dosage-tapering to the mother. Placenta. vol 58. 2018-06-08. PMID:28962699. |
although selective serotonin reuptake inhibitors have been used during pregnancy for the treatment of depression and anxiety disorders, the fetal plasma concentration profiles of them remained unclear. |
2018-06-08 |
2023-08-13 |
Not clear |
| J Näslund, F Hieronymus, J F Emilsson, A Lisinski, S Nilsson, E Eriksso. Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression. Acta psychiatrica Scandinavica. vol 136. issue 4. 2018-06-05. PMID:28859218. |
incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression. |
2018-06-05 |
2023-08-13 |
Not clear |
| Wandilson Dos Santos Rodrigues Junior, Priscilla Oliveira-Silva, Adriana da Cunha Faria-Melibeu, Paula Campello-Costa, Claudio Alberto Serfat. Serotonin transporter immunoreactivity is modulated during development and after fluoxetine treatment in the rodent visual system. Neuroscience letters. vol 657. 2018-05-28. PMID:28756191. |
the serotonin transporter (5-htt) regulates serotonin homeostasis and has been used as a target for different drugs in depression treatment. |
2018-05-28 |
2023-08-13 |
Not clear |
| Jose David Avil. Fatal Cerebral Edema, Seizures, and Hyponatremia After Trazodone Overdose. Clinical neuropharmacology. vol 40. issue 5. 2018-05-21. PMID:28816830. |
trazodone is a serotonin antagonist and reuptake inhibitor that is widely used for the treatment of depression and insomnia. |
2018-05-21 |
2023-08-13 |
Not clear |